We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Biomerieux (BIM) EUR1

Sell:€98.85 Buy:€99.80 Change: €1.10 (1.10%)
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
Sell:€98.85
Buy:€99.80
Change: €1.10 (1.10%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
Sell:€98.85
Buy:€99.80
Change: €1.10 (1.10%)
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.

Contact details

Address:
376, chemin de l'Orme
CRAPONNE
69280
France
Telephone:
+33 (4) 78872000
Website:
https://www.biomerieux.fr/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BIM
ISIN:
FR0013280286
Market cap:
€11.85 billion
Shares in issue:
118.15 million
Sector:
Health Care Equipment
Exchange:
Euronext Paris
Country:
France
Currency:
Euro
Indices:
Euronext 100

Key personnel

  • Alexandre Merieux
    Executive Chairman of the Board
  • Pierre Boulud
    Chief Executive Officer, Member of the Executive Board
  • Guillaume Bouhours
    Chief Financial Officer, Executive Vice President - Purchasing and Information Systems, Member of the Executive Committee
  • Valerie Leylde
    Executive Vice President - Human Resources, Communication and CSR, Member of the Executive Board
  • Pierre Charbonnier
    Executive Vice President - Global Quality, Manufacturing and Supply Chain, Member of the Executive Committee
  • Audrey Dauvet
    Executive Vice President - Legal Affairs and Integrity, Member of the Executive Committee
  • Yasha Mitrotti
    Executive Vice President - Industrial Microbiology, Member of the Executive Committee
  • Jennifer Zinn
    Executive Vice President - Clinical Operations
  • Charles Cooper
    Executive Director - Medical Affairs, Member of the Executive Committee
  • Celine Roger-Dalbert
    Executive Director - Research and Development, Member of the Executive Committee

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.